Who Is at Risk for Developing Clostridioides Difficile Infection?
An overview of the risk factors that contribute to the development of Clostridioides difficile infection in various health care settings.
Related Articles
FDA Approves Nirsevimab-alip to Prevent RSV in Infants, Toddlers
The approval marks the first monoclonal antibody approved to protect all infants through their first respiratory syncytial virus season.
Inflation Reduction Act, EOM, PBM Reform Remain Hot Topics on Capitol Hill
Effective implementation of the Inflation Reduction Act may allow legislators to shift their focus toward controversial pharmacy benefit manager practices, according to a panel discussion…
2023 OTC Guide
Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.
Pure Oxygen Treatment May Significantly Improve Motor Learning Processes
Study suggests supplemental oxygen may improve cognitive functions that are vital in motor learning, which can be important for people with neurological conditions or trauma.
Treatment of HER2-Low Breast Cancer Impacts Oncology Landscape
Because of its prevalence in approximately 50% of breast cancers, the outcomes of HER2-low treatment have a significant impact on patient outcomes.
Missed or Delayed Pediatric Preventative Care During COVID-19 Pandemic Influenced By Race, Enabling Factors
Study among the first to examine delayed or missed pediatric preventative care during COVID-19 that considers determinants, race, and ethnic group, according to the authors.
FDA, USP Advance Standardization, Regulation of Cannabis Nationally
Quality standards and national regulation help to establish its role as medicine.
Navigating the Path to Safe Compounding in Health Systems
Drug shortages have led to increased use of compounding pharmacy.
FDA Accepts New Drug Application for Zanubrutinib Combination for R/R Follicular Lymphoma
Zanubrutinib combined with obinutuzumab was previously granted both Fast Track and Orphan drug designations for patients with relapsed or refractory follicular lymphoma.
New, Accurate Detection Methods Necessary for Treating C. Difficile Infections
MicroRNA has shown the potential to more effectively and accurately identify C. difficile infections and manage it after diagnosis.